Skip to content
Destina Genomics
Simultaneous detection of nucleic acids and proteins
Destina GenomicsDestina Genomics
  • Company
    • About Us
    • People
      • Board
      • Management
      • Team
      • In Memoriam
  • Technology
    • Art of DGL-Tech™
    • ChemiRNA™ Tech
    • Spin-Tube Device
    • Intellectual Property
  • Products & Services
    • Products
      • Pipeline Assay Kits
      • LiverAce – Liver Injury Failure
    • Services
      • Profiling of miRNA-122
      • Develop your own Assay
    • Custom PNA synthesis
  • Investors & Partners
    • Investment Opportunity
    • Collaborations
      • ODG Device
    • Grants
  • News
    • Events
    • Press releases
    • Publications
    • Blog
    • Announcements
    • CAREER
  • Contact
  • Company
    • About Us
    • People
      • Board
      • Management
      • Team
      • In Memoriam
  • Technology
    • Art of DGL-Tech™
    • ChemiRNA™ Tech
    • Spin-Tube Device
    • Intellectual Property
  • Products & Services
    • Products
      • Pipeline Assay Kits
      • LiverAce – Liver Injury Failure
    • Services
      • Profiling of miRNA-122
      • Develop your own Assay
    • Custom PNA synthesis
  • Investors & Partners
    • Investment Opportunity
    • Collaborations
      • ODG Device
    • Grants
  • News
    • Events
    • Press releases
    • Publications
    • Blog
    • Announcements
    • CAREER
  • Contact

Announcement on the Death of our CEO Hugh Ilyine

AnnouncementsBy DestinaSeptember 24, 20202 Comments

Edinburgh 23rd September 2020 It is with great sadness that DESTINA Genomics and DESTINA Genomica announce the death of our friend, colleague and CEO Hugh Ilyine. Hugh was found at his desk having only recently been on a call where he had been his usual ebullient and energetic self. Hugh was a founding director and…

Go to Top